th8 Educational Course of the Lymphoma Working Party on "Lymphomas and Stem Cell Transplantation"

Bucharest, Romania www.embt.org 17-19 October 2012

www.ebmt.org

PresidentAlejandro Madrigal(London)

SecretaryAnna Sureda(Cambridge)

TreasurerFred Falkenburg(Leiden)

Nurses Group PresidentArno Mank(Amsterdam)

EBMT 2012 CongressPresidentJacob Passweg (Geneva)

Working PartyChairpersons

Acute LeukaemiaMohamad Mohty(Nantes)

Aplastic AnaemiaJudith Marsh(London)

Autoimmune DiseasesDominique Farge-Bancel(Paris)

Chronic LeukaemiasTheo de Witte(Nijmegen)

ImmunobiologyAndrea Velardi(Perugia)

Inborn ErrorsBobby Gaspar(London)

Infectious DiseasesSimone Cesaro(Verona)

Late EffectsAndré Tichelli(Basel)

LymphomaPeter Dreger(Heidelberg)

Paediatric DiseasesChristina Peters(Vienna)

Solid TumoursMarco Bregni(Milan)

EBMT Registered Office: P.O. Box 3151, 6202 ND Maastricht, The Netherlands Registration Number: 41166105 · VAT Number: NL8042.17.257.B01

Heidelberg, February 10, 2012

Dear Colleaque,

On behalf of the EBMT Lymphoma Working Party, we are happy to invite you to the 8th Edition of the Educational Course of the Lymphoma Working Party on Stem Cell Transplantation in Lymphomas that will be held in Bucharest (Romania) on October 18th and 19th, 2012. During the last 8 years the Course has emerged as a very productive and effective forum to bring together young researchers and transplantation fellows with experienced international experts in lymphoma and transplantation. As in previous years, travel grants for attendees from outreach countries and case report presenters will be available.

In addition, we would like to remind you that the General Meeting of the Lymphoma Working Party will be held on October 17th, also in Bucharest, just before the start of the Educational Course. You are cordially invited to join the LWP meeting and share your expertise for designing new studies and helping to re-evaluate ongoing scientific projects in the lymphoma transplant field.

We are looking forward to welcoming you in Bucharest.

Best regards,

Anna SuredaChair of the Educational Subcommittee of the LWP Secretary of the EBMT

Peter DregerChairman,EBMT Lymphoma Working Party

Board Members

Alina TanaseChairLocal Organizing Committee

October th18

October th19

15:30-18:30 General Meeting of the Lymphoma Working Party

08:00-08:15

Session 1: Opening Session, Chair: Alina Tanase08:15-08:45 Trends in Stem Cell Transplantation in Lymphomas in Romania Alina Tanase08:45-09:15 Strategies to Mobilize Stem Cells Into Peripheral Blood Harry Schouten09:45-10:15 GVHD versus GVL: Implications for allotransplantation in Ernst Holler the Lymphoma Setting

Session 2: Aggressive B Cell Lymphomas, Chair: Harry Schouten10:45-11:15 Diffuse Large B Cell Lymphoma: Conventional Therapy- Lessons to Be Learnt from Molecular Analyses Christian Gisselbrecht11:15-11:45 Salvage Therapy in Diffuse Large B Cell Lymphoma - New Options and Role of Autologous Stem Cell Transplantation Christian Gisselbrecht11:45-12:15 Allogeneic Stem Cell Transplantation - Where is the Best Place in the Treatment Algorithm of DLBCL in the R Era? Stephen Robinson12:15-12:30 Case Report 112:30-12:45 Interactive Case Report Erzsebet Benedek

Session 3: Follicular Lymphomas, Chair: Silvia Montoto14:00-14:30 Upfront Therapy of FL: Who and How - Still Need for Chemotherapy? Noel Milpied14:30-15:00 The Role of Stem Cell Transplantation in the Treatment of FL: The European FL Transplant Consensus Silvia Montoto15:00-15:15 Case Report 215:15-15:30 Interactive Case Report Smaranda Arghirescu

Session 4: Mantle Cell Lymphomas, Chair: Olivier Hermine15:45-16:15 Inside the Mantle Cell: Does "Indolent" MCL Exist and Impact Treatment Strategy? Olivier Hermine16:15-16:45 Results of Current Standard Treatments Including the Role of SCT Olivier Hermine16:45-17:15 New Drugs and Impact of Transplantation in the Salvage Situation Peter Dreger17:15-17:30 Case Report 317:30-17:45 Interactive Case Report Zsofia Varady20:00-23:00 Meet the Expert Dinner All Speakers mix up

Session 5: Hodgkin’s Lymphoma, Chair: Marek Trneny08:00-08:30 First Line therapy in Hodgkin's Lymphoma Daniel Coriu08:30-09:00 Autologous Stem Cell Transplantation Anna Sureda09:00-09:15 Interactive Case Report Anca Colita09:15-09:35 Is there Place for Allogeneic Stem Cell Transplantation in HL: No Peter Borchmann09:35-09:55 Is there Place for Allogeneic Stem Cell Transplantation in HL: Yes Anna Sureda09:55-10:25 Brentuximab Vedotin and Other New Drugs for Salvage Therapy - Has the "Rituximab" for HL Arrived Now? Marek Trneny

Session 6: Rare Lymphomas, Chair: Noel Milpied11:00-11:30 T Cell Lymphoma: Auto, Allo - When and How? Norbert Schmitz11:30-11:50 Cutaneous T Cell Lymphoma: An Indication for Allogeneic Stem Cell Transplantation? Rafael Duarte11:50-12:05 Interactive Case Report Andrei Colita12:05-12:35 Role of Stem Cell Transplantation in Waldenström's Disease Chara Kyriakou12:35-12:50 Case Report 4 12:50-13:05 Case Report 513:05-13:15 Conclusions and Farewell from the Local Organizing Physician Alina Tanase

Introduction & Welcome from the Local Organising Physician Alina Tanase

10:15-10:45

15:30-15:45 Coffee Break

10:25-11:00 Coffee Break

13:15-14:00 Optional Lunch

Coffee Break

12:45-14:00 Lunch

October th17

Agenda

Additional information

Calea Victoriei 37B Sector 1Bucharest, Romania

thThe 8 Edition of the Educational Course of the Lymphoma Working Party on Stem Cell Transplantation in Lymphomas that will be held in Bucharest (Romania) in October 18th and 19th, 2012, at:

Novotel Hotel

For further details, pleasecontact us: email address

Alina TanaseFundeni Clinical Institute, Bucharest, Romania

Anna SuredaAddenbrookes Hospital, Cambridge University, Cambridge, UK

Chara KyriakouNorthwick Park Hospital, Harrow, UK

Christian GisselbrechtHopital Saint Louis, Paris, France

Ernst HollerUniversity Regensburg, Regensburg, Germany

Harry SchoutenUniversity Hospital Maastricht, Maastricht, The Netherlands

Marek TrnenyCharles University Hospital, Prague, Czech Republic

Noel MilpiedCHU Bordeaux, Bordeaux, France

Fac

ult

y M

emb

ers Norbert Schmitz

Asklepios Klinik St. Georg, Hamburg Germany

Olivier HermineHôpital Necker, Paris, France

Peter Borchmann,University of Cologne, Cologne, Germany Peter DregerUniversity of Heidelberg, Heidelberg, Germany Rafael DuarteICO – Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain

Silvia MontotoBarts Cancer Institute, Queen Mary University of London, London, UK

Stephen RobinsonAvon Haematology UnitBristol, UK

Str. Vasile Lucaciu 60 sector 3, Bucharest